Hepatitis B virus-human immunodeficiency virus co-infection in France: A cross-sectional multicentre study

Epidemiology and Infection

Volumn 135, Issue 3, 2007, Pages 409-416

  Sene D ^a   Pol, S ^b   Piroth, L ^b   Goujard, C ^b   Dellamonica, P ^b   Moussali, J ^a   Rey, D ^c   Loustaud Ratti, V ^b   Alric, L ^b   Chousterman, M ^d   Borsa Lebas, F ^b   Boucher, O ^b   Sereni D ^b   Cacoub, Patrice ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Civil de Strasbourg ^*

^c Civil de Strasbourg   (France)

^d Intercommunal de Créteil   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ALPHA INTERFERON; ANTIRETROVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON; TENOFOVIR; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FRANCE; GENDER; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PREVALENCE; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SUPERINFECTION;

EID: 33947376851     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006947     Document Type: Article

References (35)

1. Lai CL, et al. Viral hepatitis B. Lancet 2003; 362: 2089-2094.
2. Goudeau A, Dubois F. Incidence and prevalence of hepatitis B in France. Vaccine 1995; 13 (Suppl. 1): S22-25.
3. Pillonel J, et al. Prevalence of HBV, HCV, HIV and HTLV in autologous blood donors in France between 1993 and 2000 [in French]. Transfusion Clinique et Biologique 2002; 9: 289-296.
4. Hadler SC, et al. Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. Journal of Infectious Diseases 1991; 163: 454-459.
5. Eskild A, et al. Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 1992; 6: 571-574.
6. Ockenga J, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. Journal of Hepatology 1997; 27: 18-24.
7. Solomon RE, et al. Human immunodeficiency virus and hepatitis delta virus in homosexual men. A study of four cohorts. Annals of Internal Medicine 1988; 108: 51-54.
8. Gilson RJ, et al. Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection. AIDS 1997; 11: 597-606.
9. Kellerman SE, et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. Journal of Infectious Diseases 2003; 188: 571-577.
10. Bodsworth N, Donovan B, Nightingale BN. The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: A study of 150 homosexual men. Journal of Infectious Diseases 1989; 160: 577-582.
11. Koblin BA, et al. Effect of duration of hepatitis B virus infection on the association between human immunodeficiency virus type-1 and hepatitis B viral replication. Hepatology 1992; 15: 590-592.
12. Mai AL, et al. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. Journal of Clinical Gastroenterology 1996; 22: 299-304.
13. Housset C, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992; 15: 578-583.
14. Colin JF, et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999; 29: 1306-1310.
15. Thio CL, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360: 1921-1926.
16. Cable E. Intraobserver and interobserver variations in liver biopsy further improvements than those reported here could be interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15-20.
17. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
18. Di Marco V, et al. The long-term course of chronic hepatitis B. Hepatology 1999; 30: 257-264.
19. Janssen HL, et al. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology 1999; 30: 238-243.
20. van Zonneveld M, et al. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology 2004; 39: 804-810.
21. Perrillo RP, Regenstein FG, Roodman ST. Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Annals of Internal Medicine 1986; 105: 382-383.
22. Goldin RD, et al. Histological and immunohistochemical study of hepatitis B virus in human immunodeficiency virus infection. Journal of Clinical Pathology 1990; 43: 203-205.
23. Marcellin P, et al. Adefovir dipivoxil for the treatment of hepatitis Be antigen-positive chronic hepatitis B. New England Journal of Medicine 2003; 348: 808-816.
24. Hadziyannis SJ, et al. Adefovir dipivoxil for the treatment of hepatitis Be antigen-negative chronic hepatitis B. New England Journal of Medicine 2003; 348: 800-807.
25. Myers RP, et al. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003; 17: 721-725.
26. Myers RP, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. Journal of Hepatology 2003; 39: 222-230.
27. Poynard T, et al. A comparison of fibrosis progression in chronic liver diseases. Journal of Hepatology 2003; 38: 257-265.
28. Soto B, et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. Journal of Hepatology 1997; 26: 1-5.
29. Martin-Carbonero L, et al. Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: A European collaborative study. Clinical and Infectious Diseases 2004; 38: 128-133.
30. Romeo R, et al. Hepatitis C is more severe in drug users with human immunodeficiency virus infection. Journal of Viral Hepatology 2000; 7: 297-301.
31. Gaeta GB, et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. Journal of Hepatology 2003; 39: 1036-1041.
32. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. International Journal of Cancer 1998; 75: 347-354.
33. Hadziyannis SJ. Review: Hepatitis delta. Journal of Gastroenterology and Hepatology 1997; 12: 289-298.
34. Zarski JP, et al. Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. French Multicentre Group. Journal of Hepatology 1994; 20: 636-640.
35. Hadziyannis SJ, Vassilopoulos D. Hepatitis Be antigen-negative chronic hepatitis B. Hepatology 2001; 34: 617-624.